• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估源自蜱细胞培养的边缘无形体灭活疫苗的有效性。

Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture.

作者信息

Lasmar Pedro Veloso Facury, Carvalho Antônio Último de, Facury Filho Elias Jorge, Bastos Camila Valgas, Ribeiro Múcio Flávio Barbosa

机构信息

Departamento de Clínica da Escola de Veterinaria, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Rev Bras Parasitol Vet. 2012 Apr-Jun;21(2):112-7. doi: 10.1590/s1984-29612012000200008.

DOI:10.1590/s1984-29612012000200008
PMID:22832750
Abstract

The protective efficacy of an inactivated vaccine from Anaplasma marginale that was cultured in tick cells (IDE8) for use against bovine anaplasmosis was evaluated. Five calves (Group 1) were inoculated subcutaneously, at 21-day intervals, with three doses of vaccine containing 3 × 10(9) A. marginale initial bodies. Five control calves received saline solution alone (Group 2). Thirty-two days after the final inoculation, all the calves were challenged with approximately 3 × 10(5) erythrocytes infected with A. marginale high-virulence isolate (UFMG2). The Group 1 calves seroconverted 14 days after the second dose of vaccine. After the challenge, all the animals showed patent rickettsemia. There was no significant difference (p > 0.05) between the Group 1 and 2 calves during the incubation period, patency period or convalescence period. All the animals required treatment to prevent death. The results suggest that the inactivated vaccine from A. marginale produced in IDE8 induced seroconversion in calves, but was not effective for preventing anaplasmosis induced by the UFMG2 isolate under the conditions of this experiment.

摘要

对一种在蜱细胞(IDE8)中培养的用于预防牛无形体病的边缘无形体灭活疫苗的保护效力进行了评估。五头犊牛(第1组)每隔21天皮下接种三剂含3×10⁹个边缘无形体初始体的疫苗。五头对照犊牛仅接受生理盐水(第2组)。最后一次接种后32天,所有犊牛均用约3×10⁵个感染了边缘无形体高毒力分离株(UFMG2)的红细胞进行攻毒。第1组犊牛在第二剂疫苗接种后14天出现血清转化。攻毒后,所有动物均出现明显的立克次体血症。在潜伏期、发病期或恢复期,第1组和第2组犊牛之间无显著差异(p>0.05)。所有动物均需治疗以防止死亡。结果表明,在IDE8中生产的边缘无形体灭活疫苗可诱导犊牛血清转化,但在本实验条件下,对预防UFMG2分离株诱导的无形体病无效。

相似文献

1
Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture.评估源自蜱细胞培养的边缘无形体灭活疫苗的有效性。
Rev Bras Parasitol Vet. 2012 Apr-Jun;21(2):112-7. doi: 10.1590/s1984-29612012000200008.
2
Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves.在实验感染牛中,两种巴西分离株无外膜蛋白的边缘无浆体之间存在保护作用。
Vet J. 2010 Dec;186(3):374-8. doi: 10.1016/j.tvjl.2009.09.013. Epub 2009 Oct 17.
3
Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.用源自蜱细胞培养物和牛红细胞的边缘无浆体对牛进行疫苗接种,随后用感染的蜱进行攻击暴露。
Vet Microbiol. 2002 Oct 22;89(2-3):239-251. doi: 10.1016/s0378-1135(02)00206-7.
4
Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.地理上不同的边缘无浆体虫分离株之间的交叉保护似乎受到有限的抗体反应的限制。
Transbound Emerg Dis. 2013 Nov;60 Suppl 2:97-104. doi: 10.1111/tbed.12125.
5
Immunization of cattle with Anaplasma marginale derived from tick cell culture.用源自蜱细胞培养物的边缘无形体对牛进行免疫接种。
Vet Parasitol. 2001 Dec 3;102(1-2):151-61. doi: 10.1016/s0304-4017(01)00519-2.
6
Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.使用由边缘无浆体雅博蒂卡巴尔菌株制备的DNA疫苗(pcDNA3.1/MSP1b)对牛进行免疫接种。
Ann N Y Acad Sci. 2004 Oct;1026:257-66. doi: 10.1196/annals.1307.040.
7
Immune response and biochemistry of calves immunized with rMSP1a ( Anaplasma marginale) using carbon nanotubes as carrier molecules.
Rev Bras Parasitol Vet. 2018 Apr-Jun;27(2):191-202. doi: 10.1590/s1984-296120180029. Epub 2018 May 24.
8
Identification of a vertically transmitted strain from Anaplasma marginale (UFMG3): Molecular and phylogenetic characterization, and evaluation of virulence.
Ticks Tick Borne Dis. 2016 Feb;7(1):80-84. doi: 10.1016/j.ttbdis.2015.09.001. Epub 2015 Sep 7.
9
Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.边缘无浆体田间攻毒:一种与攻毒株msp1α可变区部分序列相同的灭活免疫原的保护作用
Vaccine. 2007 Jan 5;25(3):519-25. doi: 10.1016/j.vaccine.2006.07.049. Epub 2006 Aug 7.
10
Anaplasma marginale inactivated vaccine: dose titration against a homologous challenge.边缘无形体灭活疫苗:针对同源攻击的剂量滴定
Comp Immunol Microbiol Infect Dis. 2000 Oct;23(4):239-52. doi: 10.1016/s0147-9571(99)00076-4.

引用本文的文献

1
Bovine Anaplasmosis: Will there ever be an almighty effective vaccine?牛无形体病:会有万能有效的疫苗吗?
Front Vet Sci. 2022 Oct 5;9:946545. doi: 10.3389/fvets.2022.946545. eCollection 2022.
2
The Novel Zoonotic Pathogen, , Infects Human Erythrocytes, HL-60, and TF-1 Cells .新型人畜共患病原体感染人类红细胞、HL-60细胞和TF-1细胞。 (你原文中病原体名称部分缺失,请补充完整以便准确翻译)
Pathogens. 2021 May 14;10(5):600. doi: 10.3390/pathogens10050600.
3
Knockdown of the Rhipicephalus microplus cytochrome c oxidase subunit III gene is associated with a failure of Anaplasma marginale transmission.
敲低 Rhipicephalus microplus 细胞色素 c 氧化酶亚基 III 基因与 Anaplasma marginale 传播失败有关。
PLoS One. 2014 May 30;9(5):e98614. doi: 10.1371/journal.pone.0098614. eCollection 2014.
4
Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.用活的、培养的边缘无形体菌株免疫诱导的保护性免疫。
Vaccine. 2013 Aug 2;31(35):3617-22. doi: 10.1016/j.vaccine.2013.04.069. Epub 2013 May 9.